A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...

Other pharmaceutical companies are also entering the race to develop oral GLP-1 treatments. Eli Lilly is testing an experimental drug called orforglipron which targets the same pathway as semaglutide.

Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x ...

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Discover what the supplement Lemme GLP-1 Daily does and whether its ingredients are really effective for weight and blood ...

According to a recent poll, one in eight American adults report that they have used a glucagon-like peptide-1 agonist ...

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so ...

Six individuals have received this year's Lasker Awards in the areas of basic research, clinical research, and public service ...

As a critical care doctor, I have long considered inflammation a necessary evil, the mechanism through which our bodies sound ...

Researchers examine the role of GLP-2 in regulating food intake through its effects on gastrointestinal motility and satiety ...